home / stock / dbvt / dbvt news


DBVT News and Press, DBV Technologies S.A. From 03/04/22

Stock Information

Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com

Menu

DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...

DBVT - Humanigen gains as CEO more than doubles stake

Clinical-stage biotech, Humanigen (NASDAQ:HGEN) has added ~6% in the pre-market after two of the senior officers of the company, including Chief Executive Cameron Durrant, disclosed insider purchases through SEC filings on Friday. On Mar. 02, Cameron has bought 40,000 company s...

DBVT - DBV Technologies stock slumps 21% amid FY revenue decline, plans on Peanut patch

DBV Technologies (NASDAQ:DBVT) stock declined pre-market following its FY21 results which beat analysts' estimates. Full year 2021 revenue fell -49.38% Y/Y to $5.71M. Net loss decreased to -$97.81M, compared to -$159.56M in 2020. Research and development expenses declined to $70.34M...

DBVT - DBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q4 2021 Results - Earnings Call Transcript

DBV Technologies S.A. (DBVT) Q4 2021 Earnings Conference Call March 03, 2022 05:00 PM ET Company Participants Anne Pollak - Head of Investor Relations Daniel Tassé - Chief Executive Officer Sébastien Robitaille - Chief Financial Officer Pharis Mohideen - Chief Medical Officer Confer...

DBVT - DBV Technologies GAAP EPS of -$1.78 beats by $0.28, revenue of $5.70M beats by $0.83M

DBV Technologies press release (NASDAQ:DBVT): FY GAAP EPS of -$1.78 beats by $0.28. Revenue of $5.70M (-49.5% Y/Y) beats by $0.83M. For further details see: DBV Technologies GAAP EPS of -$1.78 beats by $0.28, revenue of $5.70M beats by $0.83M

DBVT - DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates

Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates m VP Pivotal Protocol Complete and Ready for Submission to FDA DBV Continues to E ngage in Productive Exchanges with FDA Cash ...

DBVT - KLXE and ORN among mid-day movers

Gainers: Indonesia (NYSE:INDO) +60%. Tonix Pharmaceutical (NASDAQ:TNXP) +51%. Eos Energy Enterprises (NASDAQ:EOSE) +33%. Rimini Street (NASDAQ:RMNI) +30%. KLX Energy Services (NASDAQ:KLXE) +18%. DBV Technologies (NASDAQ:DBVT) +17%. Barrett Business Services (NASDAQ:BBSI) +16%. Ferroglobe (NAS...

DBVT - DBV Technologies, EyePoint top healthcare gainers; NuCana, MediWound lead losers' pack

Gainers: DBV Technologies (NASDAQ:DBVT) +16%. EyePoint Pharmaceuticals (NASDAQ:EYPT) +14%. Antares Pharma (NASDAQ:ATRS) +10%. Nuvalent (NASDAQ:NUVL) +8%. Aquestive Therapeutics (NASDAQ:AQST) +7%. Losers: NuCana (NASDAQ:NCNA) -54%. MediWound (NASDAQ:MDWD) -15%.&#x...

DBVT - BLRX, EOSE and SPIR among premarket gainers

Indonesia Energy (NYSE:INDO) +46%. Imperial Petroleum (NASDAQ:IMPP) +20%. DBV Technologies (NASDAQ:DBVT) +19%. Canaan (NASDAQ:CAN) +18% on Q4 results. Cedar Realty (NYSE:CDR) +14% on acquisition by Wheeler REIT. Eos Energy (NASDAQ:EOSE) +14%. Wheeler Real Estate (NASDAQ:WH...

DBVT - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! In preparation for another busy day of trading, we’ve put together a list of the biggest pre-market stock movers for Thursday! Source: ventdusud / Shutterstock.com We’ve got ear...

DBVT - DBV Technologies FY 2021 Earnings Preview

DBV Technologies (NASDAQ:DBVT) is scheduled to announce FY earnings results on Thursday, March 3rd, after market close. The consensus EPS Estimate is -$0.48 (+83.7% Y/Y) and the consensus Revenue Estimate is $4.87M (-56.8% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisio...

Previous 10 Next 10